Compliance
The EPNS 2019 Congress is compliant with the provisions of the MedTech Europe Code of Ethical Business Practice.
The 3rd EPNS International Advances in Neuromodulation in Children Symposium is compliant with the provisions of the MedTech Europe Code of Ethical Business Practice.
Continuing Medical Education
The 13th European Paediatric Neurology Society (EPNS) Congress, Athens, Greece, 17/09/2019- 21/09/2019 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 24 European CME credits (ECMEC®s). The 3rd EPNS International Advances in Neuromodulation in Children Symposium, Athens, Greece, 16/09/2019-17/09/2019 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 13 European CME credits (ECMEC®s).
3rd EPNS Neuromodulation Symposium
EPNS is proud to announce the organization of the 3rd EPNS International Advances in Neuromodulation in Children Symposium, which will take place at the Megaron Athens International Conference Centre (MAICC), on September 16th and 17th, 2019.
The 3rd Neuromodulation Symposium is a separate meeting, organised by Dr. Jean-Pierre Lin, and held under the auspices of the EPNS, before the Congress.
Programme
Monday | 16 September 2019 | Skalkotas Hall
08:00-09:00 Badge pick-up and Registration09:00-09:15 WELCOME MESSAGE
Jean-Pierre Lin (United Kingdom)
09:00-10:45 SESSION 1: The phenomenology and physiology of movement disorders in children
Chairs: Jean-Pierre Lin (United Kingdom), Warren Marks (USA)
09:15-10:00 Developmental biology of scales for dystonia, chorea and ataxia in typically developing children
Deborah Sival (Netherlands)
10:00-10:45 The significance of motor and sensory testing in children with Periventricular Leucomalacia
Alexander Hoon (USA)
10:45-11:15 Coffee Break
11:15-12:45 SESSION 2: Neurophysiological assessments in childhood movement disorders
Chairs: Deborah Sival (Netherlands), Alexander Hoon (USA)
11:15-11:45 What can we learn about movement disorders in childhood from somatosensory evoked potentials?
Verity McClelland (United Kingdom)
11:45-12:15 Corticomuscular coherence studies in typically developing children and children with dystonia
Verity McClelland (United Kingdom)
12:15-12:45 The tonic labyrinthine response as a sign of dystonia and response to Deep Brain Stimulation
Jean-Pierre Lin (United Kingdom)
12:45-13:00 Intermission
13:00-14:00 Industry Sponsored Symposium 1
14:15-15:45 SESSION 3: Neuroimaging and Early Deep Brain Stimulation in childhood dystonias
Chairs: Alexander Hammers (United Kingdom), Ata Siddiqui (United Kingdom)
14:15-15:00 FDG-PET-CT brain imaging in childhood dystonias
Alexander Hammers (United Kingdom), Stavros Tsagkaris (United Kingdom)
15:00-15:45 Early Deep Brain Stimulation in children: how early, how young, how severe?
Jean-Pierre Lin (United Kingdom) Harutomo Hasegawa (United Kingdom) Richard Selway (United Kingdom)
15:45-16:15 Coffee Break
16:15-17:00 SESSION 4: Interactive DBS targeting for dystonia
Chairs: Alexander Hammers (United Kingdom), Keyoumars Ashkan (United Kingdom)
16:15-17:00 Interactive visually-guided and parcellation (Tractography) – Guided Deep Mapping for Deep Brain Stimulation for dystonia in children
Harumoto Hasegawa (United Kingdom), Daniel Lumsden (United Kingdom)
17:00-18:00 SESSION 5: Dystonic pain and care pathways for childhood dystonias
Chairs: Warren Marks (USA), Daniel Lumsden (United Kingdom)
17:00-17:30 The response of dystonic pain to Deep Brain Stimulation
Sinead Barkey (United Kingdom)
17:30-18:00 The American Academy for Cerebral Palsy and Developmental Medicine Dystonia Care Pathway
Jean-Pierre Lin (United Kingdom)
18:00-19:00 SESSION 6: Neuromodulation for chronic pain and neuropsychiatric conditions
Chairs: Warren Marks (USA), Daniel Lumsden (United Kingdom)
18:00-18:30 Deep Brain Stimulation for phantom limb pain
David Pang (United Kingdom)
18:30-19:00 Neuropsychiatric indication for Deep Brain Stimulation
Keyoumars Ashkan (United Kingdom)
19.00 Conclusion Day 1
Jean-Pierre Lin
Tuesday | 17 September 2019 | Skalkotas Hall
09:00-09:15 WELCOME MESSAGESophia Varadkar (United Kingdom)
09:15-10:15 SESSION 7: Assessing the impact of childhood epilepsies
Chairs: Sophia Varadkar (United Kingdom), Marta Feucht (Austria)
09:15-09:45 Monitoring seizure frequency and duration
Amre Shahwan (Ireland)
09:45-10:15 The impact of seizures in childhood
Ailsa McLellan (United Kingdom)
10:15-10:45 Coffee Break
10:45-12:15 SESSION 8: Neuromodulation for childhood epilepsies
Chairs: Antonio Valentin (United Kingdom), Amre Shahwan (Ireland)
10:45-11:30 History of Vagus Nerve Stimulation
Marta Feucht (Austria)
11:30-12:15 Closed Loop Vagus Nerve Stimulation for childhood epilepsies
Sophia Varadkar (United Kingdom)
12:15-13:15 SESSION 9: Cognition function after Neuromodulation for childhood epilepsies and epileptic movement patterns
Chairs: Sophia Varadkar (United Kingdom), Warren Marks (USA)
12:15-13:15 Cognitive functioning before and after Epilepsy Neuromodulation Surgery
Sarah Rudebeck (United Kingdom)
13:15-13:30 Intermission
13:30-14:30 Industry Sponsored Symposium 2
14:30-15:00 Video Presentations Session
15:00-17:45 SESSION 10: Neuromodulation for acute and chronic CNS and systemic inflammatory disorders
Chairs: Sophia Varadkar (United Kingdom), Bruno Bonaz (France)
15:00-15:45 Neural control of the Innate Immune System
Ming Lim (United Kingdom)
15:45-16:30 Vagus Nerve Stimulation for Chronic Inflammatory Bowel Disease
Bruno Bonaz (France)
16:30-17:45 Outcome from Neuromodulation for FIRES in the Intensive Care Unit
Antonio Valentin (United Kingdom), Richard Selway (United Kingdom)
17:45-18:15 Discussion
18:15-18:30 CLOSING REMARKS
Sophia Varadkar (United Kingdom), Jean-Pierre Lin (United Kingdom)